The Ophthalmic Lasers Market size in the Asia Pacific was valued at USD 223.81 million in 2020. This value is estimated to grow at a CAGR of 4.9% to reach USD 284.29 Million by 2025. Increasing awareness levels among the people living in developing countries regarding different types of treatments available for eye relevant disorders is favoring the market in this region. China, Japan, and India are significant contributors to market development in the Asia Pacific.
Factors such as the rising older people population, increasing government initiatives, and rising removal of cataract surgeries are majorly driving the ophthalmic lasers market growth in the Asia Pacific. Growing incidence of chronic diseases such as diabetes, which may cause blindness, increasing demand for economical, harmless, and pain-free ophthalmic laser therapies, further adds fuel to the market growth in this region. Moreover, technology developments, high success rates of ophthalmic laser surgeries, a growing number of ophthalmic hospitals and clinics are directing high growth for the market from 2020 to 2025. The introduction of new healthcare equipment required in the ophthalmic laser treatments helps the market grow further.
High costs associated with laser treatments, risks related to the Lasik treatment like itching, redness, the shortage of skilled professionals are predicted to hamper the market growth to a small extent. Lack of awareness in the people living in rural areas and poor reimbursement policies impedes the market.
This research report on the Asia Pacific Ophthalmic Lasers Market has been segmented and sub-segmented into the following categories:
Based on the region, China and India are likely to increase the market because of a huge population. Also, Asia Pacific is the largest growing segment.
The market in the Asia Pacific is expected to lead by China. It is estimated to showcase a CAGR of 7.0% from 2020 to 2025 due to the high population suffering from obesity and glaucoma deficiency.
The Indian market is expected to grow at a 7.5% CAGR during the forecast period and is driven by factors such as increasing cases for cataracts. In India, cataract accounts for 62% of the blindness. During the 2016-17 period, 6.48 million cataract surgeries were performed in India. According to the Asia-Pacific Council of Optometry, nearly 15 million people are blind in India in 2018, out of which 75% are avoidable causes of blindness.
The Japanese ophthalmic lasers market is projected to have notable growth in the market during the period. The rise in well-established healthcare facilities with the latest equipment required at the time of surgeries like cataract and the number of FDA approvals towards the new devices coming into the market by the key players is likely to boost the market.
Companies leading the APAC Ophthalmic Lasers Market Profiled in the Report are Ellex Medical Lasers Limited, Topcon Corporation, Ziemer Ophthalmic Systems AG, IRIDEX Corporation, NIDEK Co., Ltd., Alcon Laboratories, Inc., Abbott Medical Optics, Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, and Lumenis Ltd.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Femtosecond Lasers
5.1.2 Excimer Lasers
5.1.3 Nd:YAG Lasers
5.1.4 Diode Lasers
5.1.5 Other Lasers
5.1.6 Y-o-Y Growth Analysis, By Product
5.1.7 Market Attractiveness Analysis, By Product
5.1.8 Market Share Analysis, By Product
5.2 Application
5.2.1 Refractive Error Correction
5.2.2 Cataract Removal
5.2.3 Glaucoma Treatment
5.2.4 Diabetic Retinopathy Treatment
5.2.5 AMD Treatment
5.2.6 Other Applications
5.2.7 Y-o-Y Growth Analysis, By Application
5.2.8 Market Attractiveness Analysis, By Application
5.2.9 Market Share Analysis, By Application
5.3 End User
5.3.1 Hospitals
5.3.2 Specialty Clinics and Ambulatory Surgery Centers
5.3.3 Y-o-Y Growth Analysis, By End User
5.3.4 Market Attractiveness Analysis, By End User
5.3.5 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Alcon Laboratories, Inc. (U.S.)
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Abbott Medical Optics, Inc. (U.S.)
8.3 Carl Zeiss Meditec AG (Germany)
8.4 Bausch & Lomb Incorporated (U.S.)
8.5 IRIDEX Corporation (U.S.)
8.6 Ellex Medical Lasers Limited (Australia
8.7 Topcon Corporation (Japan),
8.8 Ziemer Ophthalmic Systems AG
8.9 NIDEK Co., Ltd. (Japan)
8.10 Lumenis Ltd. (Israel)
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
